Certain A-Shares of SMO ClinPlus CO.,LTD. are subject to a Lock-Up Agreement Ending on 17-MAY-2023. These A-Shares will be under lockup for 373 days starting from 9-MAY-2022 to 17-MAY-2023.

Details:
The Company's holding shareholder Shihezi Xitai Equity Investment Partnership Enterprise (Limited Partnership), actual controller Lai Chunbao and his spouse Zeng Guiying, his controlled company who is a shareholder Shihezi Ruixin Equity Investment Partnership Enterprise (Limited Partnership), and shareholder Shihezi Ruizesheng Equity Investment Co., Ltd. committed, to not transfer or entrust to a third party the Company's shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months.

The Company's directors and senior management committed: to not transfer or entrust to a third party the Company's shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. After the lock-up has expired, while holding office, they committed to not transfer more than 25% of shares held each year.

The Company's shareholders Guanyou Zhaotai (Jiaxing) Equity Investment Partnership Enterprise (Limited Partnership), Ningbo Huiqiao Hongjia Equity Investment Partnership Enterprise (Limited Partnership), Xinjiang Tairui Equity Investment Partnership Enterprise (Limited Partnership), Pingtan Hongrun Yingke New Materials Venture Capital Partnership Enterprise (Limited Partnership), Xi'an Taiming Equity Investment Partnership Enterprise (Limited Partnership), Zhang Jing, Yu Lehua, Huimei Health (Tianjin) Equity Investment Fund Partnership Enterprise (Limited Partnership), and Zhuhai Gaoling Siheng Equity Investment Partnership Enterprise (Limited Partnership) and supervisor Ma Yuping committed, to not transfer or entrust to a third party the Company's shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. After the lock-up has expired, while holding office, Ma Yuping committed to not transfer more than 25% of shares held each year.